Objective. Smell dysfunctions are common with almost 20% percent of the population affected. There are no interventional solutions for these patients. The aim of this study is to investigate the feasibility and security of the balloon dilatation technique.
Methods. This paper describes interventional steps and determines the feasibility and safety of endoscopic olfactory cleft dilatation via balloon device. We included 10 nasal cavities in the study and dilated olfactory cleft areas via balloon device.
Results. We could smoothly perform the procedure and did not observe any fractures on the skull base or olfactory cleft of the cadavers after dilatation.
Conclusions. A combination of this intervention with medical treatments can be promising for smell dysfunctions.


The incidence of olfactory dysfunction is high, affecting approximately 20% of the adult population 1. The most common aetiologies are upper respiratory tract viral infection, chronic rhinosinusitis and head trauma 2. Pre-existing narrowing or stenosis of the olfactory cleft can also result in hyposmia 3. The management of olfactory dysfunction is focused on treating any reversible aetiology. Topical intranasal steroids remain the primary treatment modality 4. Olfactory training, first described by Hummel et al. in 2009, is a crucial adjunct, especially in patients with post-viral olfactory dysfunction 5.

Similarly, surgical interventions are reserved for identifiable causes when medical treatment has not resulted in clinical improvement, e.g., endoscopic sinus surgery for chronic rhinosinusitis, septoplasty for nasal obstruction 6. When surgery is undertaken on the olfactory cleft, it is usually in the context of skull base tumour resection, which ultimately results in resection of not only mucosa but also the olfactory apparatus. At present, surgical intervention is not considered for patients with idiopathic olfactory dysfunction or post-viral hyposmia.

This paper aims to describe the technical steps for endoscopic balloon dilatation of the olfactory cleft with the view of providing clinical applicability of this novel technique.

Materials and methods

Ethical considerations

This study was approved by the Central University Research Ethics Committee of the University of Liverpool (reference 4473). A total of ten nasal cavities were utilised for this study, fresh-frozen adult cadaver heads without a previous history of sinonasal surgery.

Balloon dilatation of the olfactory cleft

Two fellowship-trained rhinologists undertook all endoscopic, endonasal balloon dilatation and surgical dissections at the Human Anatomy Resource Centre at the University of Liverpool. Surgical dissection was performed with a 4mm 30° rigid endoscope connected to a high-definition monitor and camera system, utilising standard endoscopic sinus surgery instrumentation (Karl Storz, Tuttlingen, Germany).

Both 6 mm and 7 mm diameter balloons of the XprESS LoProfile ENT dilatation system (Stryker Entellus Medical™ MN, USA) were utilised in this study (Fig. 1A). The device’s malleable tip was configured for the sphenoid sinus using the supplied bending tool (Fig. 1B).

After the nasal cavity was irrigated with sterile water, endoscopic inspection of the olfactory cleft was performed, and debris was suctioned (Fig. 2A). The anatomical insertion of the middle turbinate to the skull base was then identified. An imaginary horizontal line was drawn across the leading edge of the turbinate bisecting the half of the vertical height between the skull base and the inferior edge of the middle turbinate (Fig. 2B). The dilatation device’s tip was inserted under direct endoscopic vision into the area between the nasal septum and middle turbinate, bisecting the middle turbinate half-height (Fig. 3A). With the device held stable, the LED light fiber was advanced to facilitate endoscopic confirmation of the position of the instrument tip with the skull base. The balloon was then inflated for 20 seconds using the supplied inflation syringe (Fig. 3B).

Post-dilatation inspection of the olfactory cleft

After completing the olfactory cleft dilatation, the mucosa overlying the olfactory cleft and perpendicular plate of ethmoid was inspected for tears or defects. The mucosa was then elevated to expose the underlying bone (Fig. 4A). To accentuate any potential bony defects or fracture lines, we irrigated the exposed bony area with diluted blue food dye before the endoscopic inspection was repeated (Fig. 4B). The presence of any bony defect in the skull base and perpendicular plate of ethmoid was recorded. The process was then repeated for all nasal cavities, as described above.


Endoscopic balloon dilatation of the olfactory cleft was completed in 10 nasal cavities. Six were dilated with the 6 mm balloon, and the remaining four with the 7 mm balloon. No tears or defects of the overlying mucosa were observed following balloon dilatation. After the mucosa was resected and the area irrigated with blue dye, no fractures or defects of the skull base were identified. However, one fracture oriented longitudinally was noted on the perpendicular plate of the ethmoid following dilatation with the 6 mm balloon (Fig. 5).


Synopsis of key/new findings

This study has described a novel technique of balloon dilatation of the olfactory cleft utilising standard, commercially-available sinus dilatation devices. The technical steps have been described in detail, and in our experience, this minimally invasive procedure is both straightforward and repeatable with a short learning curve. Additional instruments, such as those typically required for sinus surgery, were not utilised to complete the procedure.

This study has also attempted to address the safety aspects of this novel technique. Neither the 6 mm and 7 mm diameter balloons caused trauma to the mucosa or the skull base’s underlying bone. A single fracture was observed in one nasal cavity, which was localised to the ethmoid’s perpendicular plate. This fracture line was horizontally oriented in the sagittal plane and was over 5 mm away from the bony skull base. Despite the relative risk of bony injury occurring within the olfactory cleft following balloon dilatation, we believe that the fracture occurred in a “controlled” manner.

Strengths of the study

The dilatation device utilised in this study exerted 12-gauge atmospheric pressure (atm) consistently around all surfaces of the balloon when it is dilated with the accompanying inflation syringe. Although the pressure exerted along the surface of the balloon appears high, it should be remembered that the expansion of the balloon is limited to the maximum diameter of either 6 mm or 7 mm, and the overall pressure is distributed evenly throughout the surface of the balloon. This contrasts with a study measuring the magnitude of the forces exerted during punch osteotomy with a Blakesley forceps, where the authors reported that it required 17.80 N to breach the bony cribriform plate 7. A follow-on study by the same group highlighted that caution might be required in extrapolating force estimates from cadaver tissue to those required in living patients, which were typically higher 8.

In this study, the midpoint vertical height of the middle turbinate was used as a reference point to introduce the curved tip of the device. The insertion was undertaken with full endoscopic visualisation of the skull base. The LED light fibre was advanced to confirm the tip’s position in relation to the skull base before the balloon was introduced by fully advancing the balloon slide mechanism forward to position the balloon within the olfactory cleft. The requirement to fully visualise the anatomy and device may preclude the need for image guidance or fluoroscopic confirmation. Thus, a deviated nasal septum that obstructs visualisation of the area medial to the middle turbinate would be a relative contraindication to balloon dilatation of the olfactory cleft.

Comparisons with other studies

Olfactory cleft dilatation is a relatively new concept, first described in 2018 3. The authors described their experience with three patients suffering from olfactory dysfunction. The surgical technique undertaken consisted of lateral fracture-dislocation of the lateral wall of the olfactory cleft (i.e., middle turbinate) using a Cottle elevator and a curved olive-shaped blunt aspirator. The authors reported improved access to the olfactory cleft, with minimal trauma to the mucosa. However, it should be recognised that this technique is not repeatable and is surgeon specific. The pressure exerted by the elevator is uncontrolled and dependent on tactile feedback.

In contrast, our technique allows for controlled and uniform pressure to be exerted along the balloon’s entire length. Given that the balloon was not in contact with the bony skull base superiorly, inadvertent trauma can safely be avoided when the balloon is dilated. The additional step of advancing the LED light probe to check the position of the device tip in its proximity to the skull base before dilatation offers additional assurance that the integrity of the skull base is not violated 9.

Additionally, the dilatation of the olfactory groove with the balloon device is a safe method in terms of vascular injuries (septal branches of the anterior ethmoid artery) when compared to surgical interventions while working in this region 10.

Clinical applicability of the study

It is acknowledged that the efficacy of this intervention remains unproven in real clinical conditions and that the results described here should not be extrapolated as an indication that the technique is safe. It should be reiterated that further studies are required to ensure repeatability and veracity of the results. Nevertheless, the ability to dilate the olfactory cleft, as demonstrated in this study, opens the real possibility of offering patients who suffer from olfactory dysfunction (e.g., hyposmia) a minimally invasive intervention to maximise penetration of topical medication such as corticosteroids into this area, which is abundant with olfactory mucosa 11. Patients with post-viral olfactory dysfunction who have not improved with conventional treatments (e.g., topical intranasal steroid) may be a specific patient group to potentially benefit from this intervention. Constitutional stenosis can be mentioned.

The degree of dilatation or topical medication penetrating this area was not evaluated in this report. Indeed, whether balloon dilatation caused significant lateralisation of the middle turbinate and the resultant effects of topical penetration into the osteomeatal complex is unknown. Nevertheless, these issues are the subject of further evaluation by this research team.


Endoscopic olfactory cleft dilatation appears to be a viable technique to improve access into this anatomical region. Our study suggests that the technique is both safe and associated with a short learning curve. Given that many patients suffering from olfactory dysfunction still do not derive satisfactory outcomes from contemporary treatment modalities, the clinical efficacy of olfactory cleft dilatation should be evaluated.

Figures and tables

Figure 1..

Figure 2..

Figure 3..

Figure 4..

Figure 5..